CBX3 and pancreatic adenocarcinoma: To understand if CBX3 can promote tumor cell proliferation and invasion in PAAD, we introduced Crispr-cas9 activation plasmid to induce overexpression of CBX3 in PAAD cell line KP3L and PANC-1.